Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer-Reference-Cited by-同舟云学术

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer

Published:2015-07-03 Issue:28 Volume:6 Page:26483-26493
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Barrett Michael T.¹,Anderson Karen S.²,Lenkiewicz Elizabeth¹,Andreozzi Mariacarla¹,Cunliffe Heather E.³,Klassen Christine L.⁴,Dueck Amylou C.⁵,McCullough Ann E.⁶,Reddy Srikanth K.⁷,Ramanathan Ramesh K.⁸,Northfelt Donald W.⁸,Pockaj Barbara A.⁴

Affiliation:

1. Department of Research, Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America

2. Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America

3. Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand

4. Division of General Surgery, Section of Surgical Oncology, Mayo Clinic in Arizona, Phoenix, Arizona, United States of America

5. Section of Biostatistics, Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America

6. Department of Pathology and Laboratory Medicine, Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America

7. Vanderbilt University, Nashville, Tennessee, United States of America

8. Division of Hematology-Oncology, Mayo Clinic in Arizona, Scottsdale, Arizona, United States of America

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational Aspects in Metaplastic Breast Carcinoma;Cancers;2024-04-07

2. Correlation between stromal Th and Tc lymphocytes and PD-L1 expression in early breast cancer tumors;Folia Histochemica et Cytobiologica;2024-01-23

3. High-Resolution Profiling of Head and Neck Squamous Cells Carcinoma Identifies Specific Biomarkers and Expression Subtypes of Clinically Relevant Vulnerabilities;Current Medicinal Chemistry;2023-11-02

4. Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning;Frontiers in Pharmacology;2023-06-23

5. Molecular Farming of Pembrolizumab and Nivolumab;International Journal of Molecular Sciences;2023-06-12